CCL22 is highly expressed in a variety of malignant tumors including ovarian tumor, colorectal tumor, breast tumor, hepatocellular carcinoma and follicular lymphoma, and is related to poor prognosis29, 30, 31, 32, 33. This evidence concerns the gene CCL22 and ovarian neoplasm.